4.5 Article

Optimizing subgroup selection in two-stage adaptive enrichment and umbrella designs

Journal

STATISTICS IN MEDICINE
Volume 40, Issue 12, Pages 2939-2956

Publisher

WILEY
DOI: 10.1002/sim.8949

Keywords

Bayesian optimization; conditional error function; subgroup analysis; utility function

Funding

  1. EU Horizon 2020 Research and Innovation Programme, Marie Sklodowska-Curie grant [633567]
  2. National Institute for Health [NIHR-SRF-2015-08-001]
  3. Medical Research Council [MR/M005755/1]
  4. Innovative Medicines Initiative 2 Joint Undertaking [853966]
  5. EU Horizon 2020 Research and Innovation Programme
  6. EFPIA
  7. Children's Tumor Foundation
  8. Global Alliance for TB Drug Development
  9. SpringWorks Therapeutics
  10. Marie Curie Actions (MSCA) [633567] Funding Source: Marie Curie Actions (MSCA)

Ask authors/readers for more resources

We propose a two-stage confirmatory clinical trial design that uses adaptation to identify the subgroup of patients benefiting from a new treatment. The study implements adaptations using the conditional error rate approach while optimizing design parameters based on a utility function considering the population prevalence of the subgroups. Results are shown for both traditional trials with familywise error rate control and umbrella trials with control only over the per-comparison type 1 error rate.
We design two-stage confirmatory clinical trials that use adaptation to find the subgroup of patients who will benefit from a new treatment, testing for a treatment effect in each of two disjoint subgroups. Our proposal allows aspects of the trial, such as recruitment probabilities of each group, to be altered at an interim analysis. We use the conditional error rate approach to implement these adaptations with protection of overall error rates. Applying a Bayesian decision-theoretic framework, we optimize design parameters by maximizing a utility function that takes the population prevalence of the subgroups into account. We show results for traditional trials with familywise error rate control (using a closed testing procedure) as well as for umbrella trials in which only the per-comparison type 1 error rate is controlled. We present numerical examples to illustrate the optimization process and the effectiveness of the proposed designs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available